This is a cause-effect relationship that demonstrates that overexpression of wild type RRAS2 is sufficient for the development of CLL in mice and suggest that 82% of the human CLL are caused by RRAS2 overexpression. Here, RRAS2 is linked to B-cell chronic lymphocytic leukemia.